Baylor Scott & White Health Researchers Determine Aspirin Intake Decreases Risk of Colorectal Cancer

Researchers at Baylor Scott & White Health have found aspirin can influence the growth of cultured colorectal cancer cells, which explains why aspirin is more effective in some patients than others. Previous studies have shown taking 600 milligrams of aspirin per day for two years can reduce colorectal cancer incidence by 63 percent. According to Baylor, the growth of the cancer cells results from a variety of “different mutational backgrounds,” resulting in some patients having a stronger reaction to the medication. Ajay Goel, Ph.D., director of gastrointestinal research and translational genomics and oncology at Baylor Scott & White Research Institute,… Full Story

UT Southwestern Discovers BRCA1 Gene is Vital for Forming Blood Cells

Researchers with the Harold C. Simmons Comprehensive Cancer Center recently discovered the BRCA1 gene is necessary for the survival of blood-forming stem cells. This could explain why patients with BRCA1 mutations do not have an elevated risk for leukemia, since the stem cells die before they have an opportunity to transform into a blood cancer. Full Story

Fort Worth Startup Encore Vision to Sell to Pharmaceutical Giant Novartis

Pharmaceutical giant Novartis International is scooping up Fort Worth-based Encore Vision as it aims to introduce the market’s first topical treatment of the eye condition presbyopia.

Novartis, a Swiss public company that raked in $49.4 billion in revenue last year, announced the agreement Tuesday, but did not disclose the financial terms. Full Story